Search Results

• • 10 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• 75-Year-Old Woman With Abdominal Pain and Constipation.

  Authors:Chineze Akusoba, Anthony Robateau, and Victor ChedidFrom:Mayo Clinic Proceedings (Vol. 97, Issue 1) Peer-Reviewed

  Jan. 20222,835 words Clinical report 1680LA75-year-oId woman presented to the emergency department with a 1-year history of worsening loose stools and abdominal discomfort. Over the course of the year, the patient had experienced regular cycles of liquid stool...

• Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.

  Author:Michael J. ArnoldFrom:American Family Physician (Vol. 103, Issue 10) Peer-Reviewed

  May 15, 2021834 words Article 1290LKey Points for Practice * The KIDs List includes a limited number of medications to avoid or use with caution in children older than one year. More medications are included for infants and neonates. * Medications...

• New molecular entity

  From:Formulary (Vol. 48, Issue 1) Peer-Reviewed

  Jan. 2013614 words Article 1570LLinzess Linaclotide IRONWOOD PHARMACEUTICALS AND FOREST PHARMACEUTICALS A guanylate cyclase-C agonist indicated for the treatment of chronic idiopathic constipation and irritable bowel syndrome with...

• How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?

  Author:Jan TackFrom:Expert Review of Gastroenterology & Hepatology (Vol. 7, Issue 5s1) Peer-Reviewed

  July 20133,640 words Report 1570LAuthor(s): Jan Tack [*] 1 Keywords : abdominal pain; bloating; constipation; European Medicines Agency; gender; irritable bowel syndrome; linaclotide; quality of life Patients with irritable bowel syndrome...

• FDA approves linaclotide for two constipation conditions

  Author:Kerri WachterFrom:Family Practice News (Vol. 42, Issue 15)

  Sept. 15, 2012283 words Brief article 1180LThe Food and Drug Administration approved linaclotide on Aug. 30 to treat two conditions: chronic idiopathic constipation and irritable bowel syndrome with constipation in adults. Linaclotide (Linzess) is...

• Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

  Authors:Brian E. Lacy, Ron Schey, Steven J. Shiff, Bernard J. Lavins, Susan M. Fox, Xinwei D. Jia, et al.From:PLoS ONE (Vol. 10, Issue 7) Peer-Reviewed

  July 29, 20157,337 words Report 1720LBackground Abdominal bloating is a common and bothersome symptom of chronic idiopathic constipation. The objective of this trial was to evaluate the efficacy and safety of linaclotide in patients with chronic...

• An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome.

  Author:Brian E. LacyFrom:Journal of Family Practice (Vol. 69, Issue 7) Peer-Reviewed

  Sept. 20204,549 words Article 1700LCONTINUING MEDICAL EDUCATION LEARNING OBJECTIVES * Describe the multiple symptoms of irritable bowel syndrome (IBS) and their impact on quality of life * Use a staged strategy for the diagnostic evaluation of IBS...

• Linaclotide: a guanylate cyclase type-C agonist for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation

  Authors:Kate M. O'Dell, Ashley E. Rummel, Noah C. Fang, and Nancy N. NguyenFrom:Formulary (Vol. 47, Issue 1) Peer-Reviewed

  Jan. 20124,339 words Drug overview, Repor... 1850LAbstract Constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation affect millions of Americans. Patients diagnosed with these conditions experience adverse symptoms that can have a negative...

• Linzess, Ironwood Pharmaceuticals and Forest

  From:Formulary (Vol. 47, Issue 10) Peer-Reviewed

  Oct. 201224 words Brief article 1640LLinaclotide (Linzess, Ironwood Pharmaceuticals and Forest) was approved to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults....

• Linzess

  From:MPR Pharmacists' Edition (Vol. 7, Issue 1)

  Spring 2013151 words Brief article 1260LCompanies: Forest and Ironwood Rx Pharmacologic class: Guanylate cyclase-C agonist Active ingredient: Linaclotide 145mcg, 290mcg; capsules. Indications: Irritable bowel syndrome with constipation (IBS-C)....